ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM— 510(k) K081165

Name: FDA 510(k) clearance K081165
Creator: U.S. Food and Drug Administration
Published: 2008-12-17

Substantially Equivalent

Spineart

FDA 510(k) clearance K081165 for ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM, Substantially Equivalent on 2008-12-17. Applicant: Spineart. Device class: 2.

Clearance details

Applicant: Spineart
Product code: Code MNH
Device class: Class 2
Regulation: 21 CFR 888.3070
Advisory panel: Orthopedic
Date received: 2008-04-24
Decision date: 2008-12-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Geneva, CH

Download summary PDF View on FDA.gov ↗

Recent devices under product code MNH

view all

K162066 — Reliance Spinal Screw System2016-12-02
K162801 — CastleLoc Spinal Fixation System2016-11-03
K162143 — FixxSure® X-Link2016-09-23
K161151 — Spinal fixation system2016-09-21
K162189 — ANAX 5.5 Spinal System2016-08-30

More clearances from Spineart

view all

K230774 — PERLA® TL System; TEKTONA® HV US Bone Cement2023-06-23
K213470 — PERLA® TL Posterior Osteosynthesis System2022-01-21
K210472 — SPINEART Navigation Instrument System2021-03-19
K203506 — PERLA® TL posterior osteosynthesis system2021-01-15
K203222 — PERLA TL Posterior Osteosynthesis System2020-12-17

Adverse events under product code MNH

product code MNH

Injury: 978
Malfunction: 793
Total: 1,771

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.